[LE STUDIUM CONFERENCE] RNA therapeutics and Neuroscience

RNA therapeutics and Neuroscience

Virtual meeting: instructions to connect are communicated upon registration.

The RNA & NEUROSCIENCE meeting aims to bring together graduate students, academic and industry scientists working in the fields of RNA and the Central Nervous System (CNS) to present their latest research results, ideas, developments, biological medical applications and discuss the current concepts and the challenges that we are facing for future research.

RNA therapeutics is a novel technology that provides a unique treatment for a variety of diseases.  While it has been a success for the COVID19 pandemic, the RNA community still has the challenge on delivering some of these RNA molecules in other parts of the body (e.g.  brain and cardiac tissue) and better specificity to have a full therapeutic effect. Therefore, this meeting will explore the novel RNA therapeutics that are been currently developing and their mechanisms to cure a variety of diseases.
Additionally, the complexity of the brain provides a unique challenge to find therapeutics to cure neurodevelopmental disorders andneurodegenerative diseases such as Alzheimer’s and ALS. These diseases are characterized by the lack of gene regulation causing protein imbalance at the synapses and therefore cell death. Thus, in this meeting we will also explore the mechanisms that cause these diseases and the novel therapeutics that are currently being developed for their cure.

This international conference is organised in the framework of the BIOPHARMACEUTICALS ARD CVL Programme.
The registration is FREE but mandatory.

KEYWORDS

RNA therapeutics, RNA molecules, Neurosciences, Neurodevelopment diseases, Neurodegenerative diseases, Central Nervous System (CNS), RNA therapy, RNA delivery and Gene regulation

CONVENORS

Dr Kathia Zaleta, LE STUDIUM / Marie Skłodowska-Curie Research Fellow
FROM: University of California San Diego (UCSD) - USA
IN RESIDENCE AT: Imaging and Brain Unit (iBrain), INSERM / University of Tours - FR​
Prof. Patrick Vourc'h
Imaging and Brain laboratory Unit (iBrain), INSERM / University of Tours - FR​

ORGANISING COMMITTEE

Dr Frédéric Laumonnier,  Imaging and Brain Unit (iBrain), INSERM / University of Tours – FR
Dr Fédérico Perche, Center for Molecular Biophysics (CBM) / CNRS – FR
Prof. Chantal Pichon, Center for Molecular Biophysics (CBM) / CNRS – FR
Prof. Patrick Vourc'h, Imaging and Brain Unit (iBrain), INSERM / University of Tours - FR
Dr Kathia Zaleta, University of California San Diego – USA    

CONFIRMED SPEAKERS

Dr Horacio Cabral, School of Engineering , The University of Tokyo - JP
Dr Ana Cristina Calvo, Department of Animal Anatomy, Embryology and Genetics, University of Zaragoza - ES
Dr Steven Dowdy, University of California San Diego (UCSD) - USA
Dr Stefano Gustincich, Italian Institute of Technology (IIT) - IT
Dr Michelle L. Hastings, Rosalind Franklin University of Medicine & Science - USA
Dr Lori L. Isom, University of Michigan Medical School - USA
Dr Débora Lanznaster, Imaging and Brain laboratory (iBrain), INSERM / University of Tours - FR
Dr Jean-René Martin, The Paris-Saclay Institute of Neuroscience (NeuroPSI) / CNRS, University Paris-Saclay - FR
Dr Liliane Massade, Diseases and Hormones of the Nervous System (DHNS), INSERM /CNRS /  University of Paris-Saclay & Paris Sud – FR
Dr Antonella Riccio, University College London (UCL) - UK
Dr Krzystof Sobczak, Adam Mickiewicz University - PL
Dr Jernej Ule, Francis Crick Institute - UK

POSTERS (ABSTRACTS SUBMISSION)

Abstracts for poster presentation should be submitted before Monday 25th April 2022. 

Please upload your abstract during the registration or send it before the deadline to maurine.villiers@lestudium-ias.fr.

The number of poster presentations is limited, convenors will process a selection and confirm your presentation not later than Friday 29th April 2022.
Please download the template for poster presentation.

Posters will be made available on this webpage as PDF files for the whole duration of the meeting.

In addition, there will be a dedicated poster session each day. Poster presenters are asked to make a 3-minute / 1 slide of presentation during the session.

Following the presentations, there will be time for questions and answers